Health ❯ Healthcare ❯ Obesity

Clinical Trials

Patient Outcomes Real-World Data Weight Loss Studies

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide

Regulators are assessing new dosing options following trial results showing greater weight loss with added side effects.

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss